Physician profile
Muna Bahsali
NPI 1447945597
$6,233.27
in general payments reported to CMS, 2019-2025
67 companies · $287 in 2025
The $287 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $2,385 · 2024: $3,560 · 2025: $287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,212 · Education: $21.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,212.27 |
| Education | $21.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $661.02 | 2023-2024 | Imfinzi, Calquence, Onglyza |
| Janssen Biotech, INC. | $353.49 | 2023-2024 | Darzalex, Tecvayli, Erleada |
| Novartis Pharmaceuticals Corporation | $307.21 | 2023-2024 | |
| Incyte Corporation | $300.92 | 2023-2024 | Jakafi, Monjuvi, Pemazyre |
| Gilead Sciences, INC. | $250.73 | 2023-2024 | Trodelvy |
| Eisai INC. | $242.53 | 2023-2024 | |
| Pfizer INC. | $222.71 | 2023-2024 | |
| Abbvie INC. | $185.24 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $173.94 | 2023-2025 | Keytruda, Welireg, Lynparza |
| Novo Nordisk INC | $172.01 | 2025 | Ozempic, Rybelsus |
| Mirati Therapeutics, INC. | $160.86 | 2023-2024 | Krazati |
| Ipsen Biopharmaceuticals, INC | $147.98 | 2023-2024 | Tazverik, Onivyde, Somatuline Depot |
| Glaxosmithkline, LLC. | $147.05 | 2023-2024 | Ojjaara, Zejula, Jemperli |
| Celgene Corporation | $146.69 | 2023-2024 | Pomalyst, Reblozyl, Opdualag |
| Genzyme Corporation | $141.56 | 2023-2025 |
Show all 67 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $126.24 | 2023-2024 | Xtandi, Padcev, Vyloy |
| Genmab U.S., INC. | $125.08 | 2023-2024 | Epkinly |
| Lilly USA, LLC | $122.95 | 2023-2025 | Jaypirca, Verzenio, Amyvid |
| Takeda Pharmaceuticals U.S.A., INC. | $118.96 | 2023-2024 | Fruzaqla, Alunbrig, Ninlaro |
| Alexion Pharmaceuticals, INC. | $108.32 | 2023-2024 | Ultomiris |
| Bayer Healthcare Pharmaceuticals INC. | $94.84 | 2023-2024 | |
| Pharmacyclics LLC, An Abbvie Company | $93.09 | 2023 | Imbruvica, Epkinly |
| Daiichi Sankyo INC. | $86.56 | 2023-2024 | Enhertu |
| Taiho Oncology, INC. | $81.37 | 2023-2024 | |
| Alnylam Pharmaceuticals INC. | $79.12 | 2023-2024 | Givlaari |
| Novocure INC. | $76.71 | 2024 | Optune, Optune Lua (Novottf-200t) |
| Regeneron Healthcare Solutions, INC. | $76.23 | 2023-2024 | Libtayo |
| Aveo Pharmaceuticals, INC. | $74.86 | 2023-2024 | Fotivda |
| Rigel Pharmaceuticals, INC. | $73.93 | 2023-2024 | Rezlidhia, Tavalisse |
| Tersera Therapeutics LLC | $71.59 | 2023-2024 | Quzyttir, Xermelo |
| Coherus Oncology, INC. | $66.77 | 2023-2024 | |
| Morphosys, US INC. | $62.56 | 2023 | Monjuvi |
| Sobi, INC | $60.10 | 2023-2024 | |
| Adc Therapeutics America, INC. | $52.48 | 2023-2024 | |
| Blueprint Medicines Corporation | $49.21 | 2023-2024 | Ayvakit |
| Organon LLC | $47.45 | 2024 | |
| Amneal Pharmaceuticals LLC | $45.66 | 2023-2024 | Avastin |
| Deciphera Pharmaceuticals INC. | $44.35 | 2023-2024 | Qinlock, Tgct |
| Janssen Pharmaceuticals, INC | $44.29 | 2024 | Xarelto |
| Tactile Systems Technology INC | $40.41 | 2024 | Flexitouch Plus, Entre Plus |
| Janssen Scientific Affairs, LLC | $37.14 | 2023-2024 | Darzalex, Tecvayli, Carvykti |
| Myriad Genetic Laboratories, INC. | $37.04 | 2024 | Myrisk |
| Acrotech Biopharma INC. | $35.13 | 2024 | Beleodaq |
| Puma Biotechnology, INC. | $34.70 | 2023-2024 | |
| Pharmacosmos Therapeutics INC. | $34.63 | 2024 | Monoferric |
| Pharmaessentia USA Corporation | $34.02 | 2024 | Besremi |
| Beigene USA, INC. | $33.17 | 2024 | Tevimbra |
| E.R. Squibb & Sons, L.L.C. | $32.62 | 2023-2024 | Opdivo, Augtyro |
| Fresenius Kabi USA, LLC | $32.42 | 2024 | Stimufend |
| Celltrion USA INC. | $32.11 | 2023 | Vegzelma |
| Kite Pharma, INC. | $27.90 | 2024 | Yescarta |
| Immunogen, INC. | $24.95 | 2023 | Elahere |
| Karyopharm Therapeutics INC. | $23.85 | 2023 | Xpovio |
| Array Biopharma INC | $23.19 | 2024 | Braftovi, Mektovi |
| Seagen INC. | $22.95 | 2023 | Tivdak |
| Foundation Medicine, INC. | $21.95 | 2023 | Foundationone Liquid Cdx |
| Exact Sciences Corporation | $21.19 | 2025 | Cologuard Collection Kit |
| Recordati_rare_diseases_inc. | $20.84 | 2024 | Sylvant |
| G1 Therapeutics, INC. | $20.56 | 2023 | Cosela |
| Exelixis INC. | $20.43 | 2023 | Cabometyx |
| Kyowa Kirin, INC. | $19.99 | 2023 | Poteligeo |
| Stemline Therapeutics INC. | $19.90 | 2024 | Elzonris |
| Tempus Ai, INC | $18.59 | 2024 | Xt Cdx |
| Emd Serono, INC. | $18.28 | 2024 | |
| Genentech USA, INC. | $17.21 | 2024 | Rozlytrek, Avastin, Tecentriq |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $16.40 | 2025 | Caplyta |
| Collegium Pharmaceutical, INC. | $15.04 | 2024 | Xtampza |
Drugs and devices associated with these payments
Lenvima $243Imfinzi $226Jakafi $223Epkinly $220Calquence $200Ozempic $172Darzalex $170Xtandi $164Imbruvica $163Krazati $161Tecvayli $160Keytruda $154Sarclisa $142Monjuvi $141Trodelvy $139Pluvicto $131Erleada $119Talzenna $111Ultomiris $108Kisqali $102Ojjaara $97.50Onglyza $97.50Tazverik $92.58Enhertu $86.56Elahere $84.40Orgovyx $82.55Lonsurf $81.37Inqovi $81.37Rybrevant $79.92Givlaari $79.12Pomalyst $78.12Libtayo $76.23Fotivda $74.86Tavalisse $73.93Rezlidhia $73.93Nubeqa $73.05Xofigo $73.05Inlyta $71.90Lutathera $68.05Udenyca $66.77Jaypirca $63.34Avastin $62.87Lynparza $61.02Onivyde $55.40Pemazyre $54.87Padcev $54.80Reblozyl $53.65Tivdak $52.24Quzyttir $50.96Zejula $49.55Ayvakit $49.21Ontruzant $47.45Welireg $45.77Qinlock $44.35Xarelto $44.29Entre Plus $40.41Flexitouch Plus $40.41Optune $39.84Verzenio $39.25Adcetris $38.97Elrexfio $38.97Comirnaty $37.31Myrisk $37.04Optune Lua (Novottf-200t) $36.87Venclexta $35.72Beleodaq $35.13Monoferric $34.63Besremi $34.02Tevimbra $33.17Fruzaqla $32.92Stimufend $32.42Vegzelma $32.11Jemperli $28.90Vyloy $27.96Yescarta $27.90Akeega $26.61Tgct $25.23Alunbrig $24.84Rybelsus $24.18Xpovio $23.85Vonjo $23.36Tasigna $23.23Braftovi $23.19Mektovi $23.19Talvey $22.54Foundationone Liquid Cdx $21.95Stivarga $21.79Vitrakvi $21.79Cologuard Collection Kit $21.19Sylvant $20.84Xermelo $20.63Cosela $20.56Cabometyx $20.43Doptelet $20.08Vaxneuvance $19.99Capvaxive $19.99Vaxelis $19.99Poteligeo $19.99Gardasil 9 $19.99Rotateq $19.99
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muna Bahsali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.